This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Treatment of primary ovarian failure

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Managing premature ovarian insuffificiency

  • offer sex steroid replacement with a choice of HRT or a combined hormonal contraceptive to women with premature ovarian insufficiency, unless contraindicated (for example, in women with hormone-sensitive cancer)

  • NICE suggest that a clinician should explain to women with premature ovarian insufficiency:
    • the importance of starting hormonal treatment either with HRT or a combined hormonal contraceptive and continuing treatment until at least the age of natural menopause (unless contraindicated)
    • that the baseline population risk of diseases such as breast cancer and cardiovascular disease increases with age and is very low in women aged under 40
    • that HRT may have a beneficial effect on blood pressure when compared with a combined oral contraceptive that both HRT and combined oral contraceptives offer bone protection
    • that HRT is not a contraceptive

  • consider referring women with premature ovarian insufficiency to healthcare professionals who have the relevant experience to help them manage all aspects of physical and psychosocial health related to their condition.

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.